inspireĀ®

Hypoglossal nerve stimulation, commonly known by the brand name InspireĀ®, is a surgical treatment option for some people with moderate to severe obstructive sleep apnea (OSA) who are unable to tolerate CPAP therapy. It works by helping keep the airway open during sleep.

how is inspireĀ® preformed?

Before being considered for this treatment, patients typically undergo a sleep study and a procedure called drug-induced sleep endoscopy to confirm that airway anatomy is suitable for the device. Not all patients with OSA are candidates.

The system is implanted under the skin in the upper chest during a minor surgical procedure. It includes a small device, a breathing sensor, and a stimulation lead connected to the hypoglossal nerve, which controls tongue movement. When you sleep, the device monitors your breathing patterns. Each time you take a breath, it gently stimulates the hypoglossal nerve to move the tongue forward, helping prevent it from blocking the airway.

After implantation, the device is turned on and adjusted during follow-up visits to ensure comfort and effectiveness. Patients use a handheld remote to turn the device on before sleep and off when they wake up.

outcomes with inspireĀ®

Inspire therapy does not cure sleep apnea, but it can significantly reduce symptoms such as snoring, breathing pauses, and daytime sleepiness in appropriately selected patients. Regular follow-up with a sleep specialist or ENT provider is important to monitor results and adjust therapy as needed.

Common side effects may include mild tongue discomfort, speech changes, or temporary soreness at the incision sites, which often improve over time. Most patients can return to normal activities within a few weeks.